Vernalis, Servier enter cancer drug collaboration
European companies Vernalis PLC (developing neurology and oncology therapeutics) and Servier SA will jointly collaborate for a three-year period on the discovery of cancer drugs.
- Drug Discovery Tools
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.